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Unlike prokaryotes, a specialized eukaryotic initiation factor 2 (eIF2), in the form of the 
ternary complex eIF2*GTP*Met-tRNAiMet is utilized to deliver the initiator tRNA to the 
ribosome within all eukaryotic cells1. Phosphorylation of eIF2 is known to be central to the 
global regulation of protein synthesis under stress conditions and infection2. Another 
distinctive feature of eukaryotic translation is scanning of mRNA 5’-leaders, whose origin in 
evolution may be relevant to the appearance of eIF2 in eukaryotes. Translation initiation on 
the hepatitis C virus (HCV) internal ribosome entry site (IRES) occurs without scanning3,4.  
Whether these unique features of the HCV IRES account for the formation of the final 80S 
initiation complex is unknown. Here we show that the HCV IRES-directed translation can 
occur without either eIF2 or its GTPase activating protein eIF5. In addition to the general 
eIF2- and eIF5-dependent pathway of 80S complex assembly, the HCV IRES makes use of a 
prokaryotic-like pathway which involves eIF5B, the analogue of bacterial IF25,6, instead of 
eIF2. This switch from a eukaryotic-like mode of AUG selection to a “bacterial” one occurs 
when eIF2 is inactivated by phosphorylation, a way with which host cells counteract infection. 
The relative resistance of HCV IRES-directed translation to eIF2 phosphorylation may 
represent one more line of defense used by this virus against host antiviral responses and can 
contribute to the well known resistance of HCV to interferon based therapy.  
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Initiation factor eIF2 is a pivotal component of the translation initiation mechanism in all 
eukaryotic cells. It is absent from bacteria, thereby reflecting quite different modes of the start 
codon selection in pro- and eukaryotes. Strikingly, some viral mRNAs are efficiently translated 
under conditions when the activity of eIF2 is suppressed by phosphorylation as a result of host cells 
response to viral infection2,7. This is exactly the case of HCV RNA, reported to be refractory to 
reduced eIF2·GTP·Met-tRNAiMet ternary complex availability8. The assembly of fully functional 
48S pre-initiation complexes on the HCV IRES only requires eIF2 and eIF33. Addition of 
conventional ribosome joining factors eIF5 and eIF5B along with 60S subunits led predictably to 
80S complex formation9 (Fig. 1a). Surprisingly, omitting eIF5, a trigger of GTP hydrolysis on eIF2, 
does not abolish the 80S complex formation (Fig. 1a). The possibility of contamination with eIF5 
within the system was ruled out by Western-blotting analysis of eIF2 and eIF5B preparations and 
by the inability of β-globin mRNA to form 80S complexes when eIF5, which is essential for this 
standard system6, was absent (Fig.1b). This finding could be explained by eIF5B functioning 
instead of eIF5 as was suggested for 80S complex formation on AUG-triplets6,10,11. However, 
control experiments in which the 48S to the 80S conversion was blocked by the presence of 
GMPPNP (a non-hydrolysable analogue of GTP) also resulted in 80S complex formation, although 
at a somewhat reduced level (Fig. 1c), indicating at least a partial independence of 80S assembly on 
GTP hydrolysis. The conversion of the 48S complex into the 80S is known to require GTP 
hydrolysis by eIF2 and thus should be completely blocked by GMPPNP. Therefore, the question 
arises of whether there is an obligatory requirement for any eIF2 if there was no strict requirement 
for GTP hydrolysis? Indeed, in the presence of only ribosomal subunits, eIF3, eIF5B, and Met-
tRNAiMet we found that 80S translation initiation complexes were formed in the presence of 
GMPPNP, thereby eliminating the possibility of any residual eIF2 activity. However, eIF3 along 
with eIF5B were indispensable (Fig. 1d). The functional role of eIF3 in this very simplified process 
of 80S assembly is not yet clear.  
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Recently, a “factorless” translation initiation process has been reported for the HCV IRES at 
elevated Mg2+ concentrations12. Although we performed the assays for 80S complex formation at 
physiological ionic concentrations, sucrose gradients employed to analyze translation initiation 
complexes routinely contained elevated concentrations of Mg2+ (6 mM). However, decreasing the 
Mg2+ concentration to 2 mM during centrifugation did not abolish eIF2-independent 80S assembly 
(Fig. 1e). We failed to reproduce “factorless” 80S complex formation12 either under our 
experimental conditions or at elevated Mg2+ concentrations (data not shown).  
The functionality of the 80S initiation complexes assembled from 40S and 60S ribosomal 
subunits, eIF3, eIF5B, and Met-tRNAiMet, i.e. their ability to be engaged into the subsequent step of 
translation, the elongation of the polypeptide chain, had to be proven. To this end, we changed the 
7th triplet of the HCV ORF to a UAA stop codon and then reconstituted the translation elongation 
process from totally purified components13. The position of the stop codon was chosen in such a 
way that the ribosomes did not reach a putative frameshift site14 previously identified within the 
coding sequence of HCV RNA. The location of elongating ribosomes at the nucleotide triplet 
preceding the termination codon was identified by toeprint assay. This technique is based on the 
primer extension inhibition of reverse transcription from an oligodeoxynucleotide, which is 
hybridized 3’ to the codon of an mRNA positioned in the P-site of the ribosome. The arrest of 
reverse transcriptase always occurs at the same position, +16 to +18 nt 3’ of the first nucleotide 
residue of the codon occupying the P-site of the ribosome. Identical elongation factor-dependent 
arrests of the ribosomes can be clearly seen in Fig. 2 regardless of whether the 80S initiation 
complexes were formed with the complete set of eIFs (including eIF2) or with just eIF3 and eIF5B 
(compare lanes 3 and 7). Thus, the 80S initiation complex formed in the absence of eIF2 was totally 
functional and not an artifact. Together these data might suggest that the eukaryotic initiation factor 
eIF2 may be dispensable if scanning of a 5’ UTR does not occur, i.e. when the 40S subunit 
immediately binds at or very close to the initiator codon. This situation is analogous to that 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
08
.1
51
8.
1 
: P
os
te
d 
14
 J
an
 2
00
8
4 
observed for prokaryotes; like bacterial IF215, eIF5B plays in this case two roles: promotes binding 
of  the initiator tRNA to ribosomes and couples the ribosomal subunits with formation of the 80S 
(70S in the case of bacteria) translation initiation complex.  
Notably, in our in vitro experiments the presence of eIF2 in the reconstitution system strongly 
inhibited GTP hydrolysis-independent formation of the 80S complex (data not shown). This could 
be due to a higher affinity of the ternary complex for the 40S subunit, implying that eIF2 
outcompetes eIF5B from the 40S. It also means that eIF2 inactivation should result in a switch of 
the translation initiation modes utilized by HCV from eIF2-dependent to eIF2-independent rather 
than in a severe inhibition of its translation. 
To address the physiological relevance of these data we inactivated eIF2 via phosphorylation 
both in vitro and in vivo and studied the effect on HCV IRES-driven translation. Rabbit reticulocyte 
lysate (RRL) was treated with dsRNA to induce PKR16 and supplemented with GMPPNP to block 
the eIF2-dependent pathway at the 48S stage. Control assays were not treated with dsRNA but also 
contained GMPPNP. It was found that no 80S complexes were assembled on the HCV IRES-
containing mRNA in control lysates (Fig. 3a). In contrast, in dsRNA treated RRL 80S complexes 
were formed on the HCV IRES transcript. This was not the case for the ß-globin mRNA, a typical 
cellular mRNA which can only use the canonical eIF-2 dependent pathway of translation initiation 
(Fig. 3a, b). It is clear that eIF2 had been inactivated, at least partially, since the amount of 48S 
complexes assembled on the ß-globin mRNA was reduced (Fig. 3b). The phosphorylation of eIF2 
in the presence of dsRNA was confirmed by Western-blotting with anti phosphor-eIF2α(Ser51) 
antibodies (Fig. 3c).  These data may explain why in the presence of GMPPNP in cell extracts no 
80S complexes have been observed previously 3,17,18. They indicate that under normal conditions, 
i.e. when eIF2 is fully active, the translation initiation on the HCV IRES proceeds primarily 
through the eIF2-dependent pathway.  
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The in vitro experiments were complemented with those performed using transfected cells. 
HEK293T cells were first treated with various reagents which elicited eIF2 phosphorylation either 
by activation of various eIF2 kinases (PKR by dsRNA transfection, PERK by DTT19, or HRI by 
sodium arsenite20) or by inhibition of PP1 phosphatase (by okadaic acid21) and then transfected with 
a mixture of a standard cap-dependent mRNA and the HCV IRES containing monocistronic 
mRNA. As seen in Fig. 4, all these treatments affected much less the HCV IRES-driven translation 
than that directed by a standard 5’-UTR. Importantly, the translation directed by certain 
picornavirus IRESes, like HRV or EMCV, were inhibited by these treatments to the same extent as 
cap-dependent translation (Fig. 4, data not shown). Interestingly, treatment with IFNα, widely used 
in HCV therapy, also lead to relative resistance of the HCV RNA translation.  Thus, consistent with 
other previously reported data7,8,22, eIF2-inactivation does not lead to severe inhibition of HCV 
IRES-driven translation. The data described above present for the first time the mechanistic 
explanation of this phenomenon, demonstrating the existence of the alternative, eIF2-independent, 
pathway of translation initiation for the HCV RNA.  The switch from a eukaryotic-like mode of 
AUG selection to a “bacterial” one occurs when eIF2 is inactivated by phosphorylation, a way with 
which host cells counteract infection. Thus, presented data throw a bridge over evolutionary 
different modes of translation initiation.  
Methods Summary 
Purification of ribosome subunits, initiation factors, and Met-tRNAiMet. Ribosomal subunits, 
initiation and elongation factors were purified from RRL or Krebs-2 ascites cells or were expressed 
in E.coli as described13,23,24. 
Assembly and analysis of translation initiation complexes. Ribosomal complexes were 
assembled and analyzed by sucrose gradient centrifugation or toeprinting as described3,23. For in 
vitro translation elongation experiments factors eEF1H, eEF2, and total aminoacylated tRNA were 
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added to preformed 80S complexes13. For in vitro eIF2 inhibition, 20 ng of synthesized dsRNA13
were added to 14 μl of RRL (Promega) and incubated for 15 min at 30oC, then lysate was 
supplemented with GMPPNP and ribosomal complexes were assembled as described previously23. 
Plasmids and in vitro transcription. Plasmids encoded for mRNAs with β-globin23 or HCV3 5’-
UTRs for ribosomal complexes assembly have been described. For cells transfection 
polyadenylated mRNAs were synthesized using PCRs product as a template, T7-promoter and 50 nt 
poly(A)-tail being introduced by corresponding primers25. 
In vivo studies. Cell culture manipulations and RNA transfection procedures were performed as 
described25. Exponentially growing HEK293T cells were replated to 24-well plates at densities 1:2, 
IFNα was added where indicated to the final concentration 1000 ME/ml. After 12 hours of growth, 
2 μg/ml dsRNA with Lipofectamine2000 (Invitrogen) was added for another 1 hour, or else 2,5 
mM DTT, 2 mM NaAsO2 or 1 μM okadaic acid (Calbiochem) were added for 30 minutes, followed 
by transfection of reporter mRNAs. The reporter expression was measured 2 hours after 
transfection. 
Western-blotting. Cells for Western-blotting were grown in parallel with cells for transfection, 
similarly treated with the effectors, and  harvested 30 min after (or 1 h in the case of dsRNA 
treatment). The equal amounts of cell lysates were resolved by SDS-PAGE and probed with the 
anti-phosphor-eIF2α(Ser51) antibodies (Cell Signaling) or anti-eIF2α antibodies (a kind gift from 
W.C.Merrick). 
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Figure 1. Assembly of 80S translation initiation complexes on the HCV IRES and β-
globin mRNAs. Sucrose density gradient centrifugation of 80S complexes reconstitution 
on (a) the HCV IRES with GTP, Met-tRNAMeti, 40S, 60S, eIF2, eIF3 with omission of eIF5 
or eIF5B as indicated and (b) the β-globin mRNA with GTP, Met-tRNAMeti, 40S, 60S, eIF1, 
eIF1A, eIF2, eIF3, eIF4A, eIF4B and eIF4F with or without eIF5 or eIF5B as indicated. (c)
80S complexes assembled on the HCV mRNA with the complete set of factors, GTP being 
substituted for its nonhydrolysable analog GMPPNP. (d) 80S complexes formed with 
GMPPNP, 40S, 60S, eIF3 and eIF5B or with omission of one of these factors. (e) analysis 
of 80S complexes reconstituted on the HCV IRES RNA in sucrose gradients containing 2 
or 5mM Mg2+ (see text). 
Figure 2. 80S complexes formed without eIF2 are competent for translational 
elongation. 80S complexes were assembled from 40S, 60S, eIF3, eIF5B, eIF2 and eIF5 
as indicated on the HCV mRNA bearing a  termination codon at the 7th amino acid 
position, and then elongation factors were added. Initiation and termination codons and 
relevant reverse transcription stops are indicated by arrows. 
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Figure 3. eIF2 phosphorylation activates the alternative pathway for 80S formation 
on the HCV IRES in RRL. The HCV mRNA (a) and β-globin mRNA (b) were incubated in 
RRL first treated with dsRNA and GMPPNP, and then ribosome complexes were resolved 
by sucrose gradient centrifugation. (c) eIF2 phosphorylation was confirmed by Western 
blotting with antibodies specific for eIF2(Ser51)-P. Lanes are: 1 – untreated, 2 – dsRNA-
treated. 
Figure 4. HCV IRES directed translation is relatively resistant to eIF2 inactivation in 
vivo. HEK293T cells were treated with 2 μg/ml dsRNA, 2.5 mM DTT, 2 mM sodium 
arsenite, 1 μM okadaic acid or 1000 ME/ml IFNα as indicated, and then either (a) 
transfected with the mixture of capped Rluc and HCV-Fluc or HRV-Fluc mRNAs, 
harvested 2 hrs later and assayed for reporter protein expression, or (b) lysed and probed 
for eIF2 phosphorylation or total eIF2 amount (lanes are: 1 – untreated, 2 – dsRNA, 3 – 
DTT, 4 – arsenite, 5 - OA, 6 - IFNα). Results are means ± s.d. of three representative 
experiments performed in triplicate. 
Methods 
Purification of ribosome subunits, initiation factors, and Met-tRNAiMet. 40S, 60S, eIF4F, eIF5, 
eIF5B and eEF1H were isolated from RRL, eIF2 and eIF3 were purified from Krebs-2 ascites cells. 
eIF1, eIF1A, eIF4A, eIF4B, and MetRS were expressed in E.coli. Rabbit eEF2 was a kind gift from 
L.P.Ovchinnikov. Met-tRNAiMet  was prepared as described13. The S100 supernatant from ascites 
cells, freed from nucleic acids by passing through DEAE-cellulose at 0.25 M KCl and ammonium 
sulfate precipitation, was used as a source of mammalian aminoacyl-tRNA synthetases. Total calf 
liver tRNA (Novagen) was aminoacylated using a protocol similar to that which was employed for 
the aminoacylation of tRNAiMet. 
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Assembly and analysis of translation initiation complexes. 48S complexes were assembled on 
the β-globin mRNA by incubating 0.5 pmol of mRNA for 10 min at 30oC in a 20-μl reaction 
volume that contained the reconstitution buffer (20 mM Tris-HCl, pH 7.5, 120 mM KOAc, 2.5 mM 
Mg(OAc)2, 0.1 mM EDTA, 1 mM DTT), 0.4 mM GTP or GMPPNP, 1 mM ATP or AMPPNP, 0.25 
mM spermidine-HCl, 5 pmol of Met-tRNAiMet, eIF1 (10 pmol), eIF1A (10 pmol), eIF2 (8 pmol), 
eIF3 (5 pmol), eIF4A (10 pmol), eIF4B (6 pmol), eIF4F (2.3 pmol), 40S ribosomal subunits (2,5 
pmol). In the case of the 80S assembly, preformed 48S complexes were supplemented with 60S 
subunits (2.5 pmol), eIF5B (3 pmol), eIF5 (3 pmol) and incubated for additional 10 minutes. In the 
case of the HCV mRNA, 48S and 80S complexes were assembled similarly, except eIF1, 1A, 4A, 
4B, 4F, and ATP were omitted (also see text). For in vitro translation elongation experiments 
factors eEF1H (4 µg), eEF2 (1 µg), and total aminoacylated tRNA (2 µg) were added to preformed 
80S complexes as described13. For sucrose gradient centrifugation analysis mRNAs were labeled 
cotranscriptionally with α-[32P]-UTP and assembled complexes were centrifuged through 5-20% 
linear sucrose gradient for 3.5 h at 33,000 rpm in SW41 rotor (Beckman). For toeprinting 5'-
GGGATTTCTGATCTCGGCG-3' oligonucleotide was used3. Assembled complexes were analyzed 
by primer extension using AMV RT (Promega) essentially as described23. cDNA products were 
analyzed by electrophoresis through 6% polyacrylamide sequencing gel. 
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